Russian scientists, pharmacists develop a unique drug for cancer patients, which will not have side effects and can be addictive. It is assumed that a drug will go on sale by 2019. About it reports the edition «news».
As told the Russian researchers are now developing a drug is preclinical testing, which are moving very successfully. Drug testing in the Institute of problems of chemico-energy technologies SB RAS in Tomsk. The drug is intended for cancer patients and patients with heart disease, particularly ischemia and myocardial infarction. The drugs is carried out in the framework of the state program «Development of pharmaceutical and medical industry of the Russian Federation for the period till 2020 and further prospect».
The notability of this drug is that it uses a substance hexaazatetracyclo, which is not contained in any known cure. Its main feature is malotoksicnam: it is not addictive and has almost no side effects.
Earlier also it was reported that Russian scientists from the Urals have created a device for the treatment of depression.